Panacea Life Sciences Holdings, Inc. financial data

Symbol
PLSH on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
5910 South University Blvd, C18 193, Greenwood Village, CO
State of incorporation
Nevada
Fiscal year end
December 31
Former names
Exactus, Inc. (to 10/26/2021), Spiral Energy Tech., Inc. (to 3/4/2016), Solid Solar Energy, Inc. (to 8/7/2013)
Latest financial report
10-Q - Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 27.7 % -40.4%
Quick Ratio 22.7 % -24.7%
Debt-to-equity -343 % +83.1%
Return On Assets -42.6 % -4.56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares +19.5%
Common Stock, Shares, Outstanding 18.3M shares +18.1%
Entity Public Float 3.53M USD -68.5%
Common Stock, Value, Issued 1.83K USD +18.1%
Weighted Average Number of Shares Outstanding, Basic 16.5M shares +10.2%
Weighted Average Number of Shares Outstanding, Diluted 16.5M shares +10.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.76M USD +50.4%
Cost of Revenue 1.2M USD -8.73%
General and Administrative Expense 1.45M USD +62.7%
Operating Income (Loss) -5.31M USD -0.37%
Nonoperating Income (Expense) -2.36M USD +17.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.67M USD +5.91%
Net Income (Loss) Attributable to Parent -7.67M USD +5.91%
Earnings Per Share, Basic -0.45 USD/shares +22.4%
Earnings Per Share, Diluted -0.45 USD/shares +18.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 108K USD +47%
Marketable Securities, Current 9.5K USD -99%
Accounts Receivable, after Allowance for Credit Loss, Current 271K USD -1.43%
Inventory, Net 4.06M USD -0.79%
Assets, Current 4.64M USD -21.9%
Property, Plant and Equipment, Net 6.07M USD -16.5%
Operating Lease, Right-of-Use Asset 3.69M USD +16.9%
Intangible Assets, Net (Excluding Goodwill) 3.01M USD
Goodwill 3.01M USD +37.7%
Assets 17.4M USD -6.17%
Accrued Liabilities, Current 593K USD
Liabilities, Current 20.4M USD +28.3%
Operating Lease, Liability, Noncurrent 3.07M USD +6.08%
Other Liabilities, Noncurrent 3.57M USD 0%
Liabilities 27M USD +20.9%
Retained Earnings (Accumulated Deficit) -35.4M USD -27.7%
Stockholders' Equity Attributable to Parent -9.62M USD -153%
Liabilities and Equity 17.4M USD -6.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -357K USD -13.8%
Net Cash Provided by (Used in) Financing Activities 369K USD -6.71%
Net Cash Provided by (Used in) Investing Activities -5K USD +67.1%
Common Stock, Shares Authorized 650M shares 0%
Common Stock, Shares, Issued 18.3M shares +18.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.72K USD -89.9%
Operating Lease, Liability 3.79M USD +16.4%
Depreciation 1.67M USD -0.57%
Payments to Acquire Property, Plant, and Equipment 5K USD -67.1%
Lessee, Operating Lease, Liability, to be Paid 4.14M USD +13.1%
Property, Plant and Equipment, Gross 13.7M USD +3.59%
Operating Lease, Liability, Current 3.06M USD +38.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 765K USD +64.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 830K USD +80.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 349K USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 474K USD +1%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 765K USD +62.9%
Additional Paid in Capital 25.7M USD +7.73%
Amortization of Intangible Assets 15.4K USD 0%
Interest Expense 1.61M USD -16.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%